Kindora
FuncionalidadesInversiones de Impacto SocialPrecios
Acerca deBlogPreguntas frecuentesDemos en vivo
Iniciar sesiónRegistrarse
    Kindora
    FuncionalidadesInversiones de Impacto SocialPrecios
    Acerca deBlogPreguntas frecuentesDemos en vivo
    Iniciar sesiónRegistrarse
    1. Inicio
    3. Fundaciones
    5. National Pediatric Cancer Foundation
    Logo de National Pediatric Cancer Foundation

    National Pediatric Cancer Foundation

    ActivoHealth Care
    TAMPA, FLSitio web8132690955

    About National Pediatric Cancer Foundation

    The National Pediatric Cancer Foundation is dedicated to funding research to eliminate childhood cancer, with a focus on finding less toxic, more effective treatments through collaborative initiatives such as the Sunshine Project.

    Focus Areas

    pediatric cancer researchclinical trialsimmunotherapy researchpatient & family support resources

    Who They Fund

    children with high‑risk pediatric cancerspediatric patients with metastatic or central nervous system (leptomeningeal) diseasepatients with specific pediatric sarcomas (Ewing sarcoma, rhabdomyosarcoma)

    Funding Style

    clinical trials supporttranslational/early-phase research fundingdisease-specific challenge/project grants

    About National Pediatric Cancer Foundation

    National Pediatric Cancer Foundation Inc. centers its giving on collaborative pediatric cancer research, especially the Sunshine Project, which funds multi-institutional studies and clinical trials aimed at less-toxic, more-effective treatments for childhood cancer. Recent awards show the scale of that approach: $992,092 to The Research Institute at Nationwide Children’s Hospital for clinical trials under the Sunshine Project, and $850,000 to H Lee Moffit Cancer Center and Research Institute Foundation Inc for the same purpose. The foundation also uses targeted challenge projects to back specific disease questions. Albert Einstein College of Medicine received separate grants of $820,000 and $713,110 for work on c-MYC-driven pediatric cancers, one-carbon metabolism in Ewing sarcoma, and related translational research. Other awards point to a research model built around hospital partners, scientist-led projects, and trial support rather than direct service delivery. The recent record includes both large trial grants and smaller project grants, with a strong emphasis on pediatric oncology therapeutics, immunotherapy, and studies for high-risk or metastatic disease. Its funding pattern suggests a research funder that supports both broad clinical infrastructure and narrower scientific problems within childhood cancer.

    What National Pediatric Cancer Foundation Funds

    Clinical trials are a core part of the foundation’s grantmaking. Under the Sunshine Project, it gave $657,764 to H Lee Moffit Cancer Center and Research Institute in Tampa for clinical trials, and $400,000 to The Regents of the University of California in Los Angeles for clinical trials conducted under the same initiative. The foundation also backs translational research aimed at specific pediatric cancers. It awarded $300,000 to Paratope Bio Inc for “Harnessing the power of innate antibodies for novel therapies in pediatric cancer research,” linking immunology to treatment development. In another disease-specific line, it provided $400,000 to The Regents of the University of California for “treating leptomeningeal spread of pediatric medulloblastoma with quantum radiobiology.” Challenge projects appear to be a second mechanism for focused research support, including work on c-MYC-driven pediatric cancers and Ewing sarcoma, as well as biomarker trial pillars within the Sunshine Project.

    How National Pediatric Cancer Foundation Gives

    Financial Snapshot

    Annual Giving

    $11.8M

    Total Assets

    $6.2M

    Total Revenue

    $4.4M

    Total Expenses

    $5.7M

    Typical Grant Size

    Most grants fall between $37K and $166K, with a median of $89K.

    25th Percentile

    $37K

    Median

    $89K

    75th Percentile

    $166K

    Geographic Reach

    National13 states funded

    About 24% of grants go to recipients in FL.

    Intensidad de financiamiento
    Baja
    Alta
    Sede

    Leadership

    DAVID FRAZER

    Deep Analysis

    Unlock Deep Analysis

    Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

    Get Started Free

    Similar Funders

    See Similar Funders

    Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

    Get Started Free

    ¿Quieres un Pitch Personalizado para National Pediatric Cancer Foundation?

    Regístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.

    Comenzar GratisVer Precios
    Plan gratuito disponible
    Sin contratos
    Cancela cuando quieras
    Boletín Semanal Gratuito

    The Grant Brief

    Inteligencia semanal sobre subvenciones para líderes de impacto social. Oportunidades seleccionadas, tendencias de financiamiento e ideas estratégicas — gratis.

    Únete a más de 500 líderes de impacto social. Cancela tu suscripción cuando quieras. Política de privacidad

    De confianza para equipos con misión social en organizaciones de todo el país

    Logo de Kindora

    En Kindora, combinamos información basada en datos con un enfoque humano para crear soluciones de recaudación de fondos estratégicas y significativas para organizaciones sin fines de lucro de todos los tamaños.

    Recibe The Grant Brief — inteligencia semanal sobre subvenciones, gratis

    Enlaces rápidos

    • Funcionalidades
    • Inversiones de Impacto Social
    • Acerca de nosotros
    • Misión
    • Cómo funciona
    • Precios
    • Empleos en filantropía
    • Compensación en organizaciones sin fines de lucro
    • Demo en vivo (todos los planes)
    • Demo de prospección individualBeta
    • Blog
    • Primeros pasos

    Conéctate con nosotros

    LinkedInTwitterFacebook

    © 2026 Kindora. Todos los derechos reservados.

    Política de privacidadTérminos de servicioEstado del sistema
    EIN: 59-3097333
    4 declaraciones registradas
    research study grants (targeted therapeutic development)

    Topics

    pediatric oncology therapeuticsc-MYC–targeted therapies (AU‑rich element destabilization)Ewing sarcoma targeted trialsneuroblastoma drug repurposing (HIV nucleoside reverse transcriptase inhibitors)leptomeningeal medulloblastoma treatment (quantum radiobiology)tumor microenvironment targeting for metastasisbiomarker-driven clinical trial pillars and iNKT cell–based immunotherapies

    Typical grant size sits at $37,056 at the 25th percentile, $89,258 at the median, and $166,107 at the 75th percentile, showing a mix of smaller project awards and larger trial commitments. The recent grant list includes repeated awards to the same institutions across multiple years, including H Lee Moffit Cancer Center and Research Institute, The Regents of the University of California, and Children’s Hospital of Colorado Foundation, which points to ongoing relationships rather than one-off gifts. The foundation is a grantmaking foundation, not a program that funds individuals, and it does not make program-related investments. One RFA for rhabdomyosarcoma research accepts unsolicited submissions.

    Where National Pediatric Cancer Foundation Makes Grants

    Grants are national in scope and all recent recipients are in the United States. Florida is the top state by grant count, and 24% of grants go to recipients in the foundation’s HQ state. The recent list shows multiple Florida recipients in Tampa and Gainesville, alongside frequent awards in Bronx, New York; Los Angeles, California; Aurora, Colorado; and Chapel Hill, North Carolina. This pattern reflects a U.S.-wide research network built around pediatric hospitals, universities, and cancer centers.

    Frequently Asked Questions About National Pediatric Cancer Foundation

    What kinds of pediatric cancer work does the foundation support?

    It funds pediatric cancer research, clinical trials, immunotherapy research, and patient and family support resources. Recent grants also show disease-specific work in rhabdomyosarcoma, Ewing sarcoma, neuroblastoma, and pediatric medulloblastoma.

    How large are its typical grants?

    The typical grant size is $37,056 at the 25th percentile, $89,258 at the median, and $166,107 at the 75th percentile. The recent grant list also includes much larger awards for clinical trials and challenge projects.

    Does the foundation make grants only in Florida?

    No. Its geographic scope is national, and recent grants went to recipients in several states including Florida, New York, California, Colorado, North Carolina, Ohio, Alabama, and Delaware. Florida is the top state by grant count, but it is not the only state served.

    Are there recurring grant relationships?

    Yes. Several recipients appear multiple times across recent years, including H Lee Moffit Cancer Center and Research Institute, The Regents of the University of California, Children’s Hospital of Colorado Foundation, and Albert Einstein College of Medicine. That suggests ongoing project and trial support.

    Can researchers submit unsolicited applications?

    For the RFA — Rhabdomyosarcoma Research Submissions (RFA 2025), yes: the program accepts unsolicited submissions. The Sunshine Project, by contrast, does not accept unsolicited applications.

    Latest 990 Filing

    2025

    Source: IRS Form 990-PF, fiscal year 2025.

    Recent Grants

    Most recent grants reported to the IRS.

    RecipientLocationAmountYearPurpose
    THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITALDETROIT, MI$992,0922025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    ALBERT EINSTEIN COLLEGE OF MEDICINEBRONX, NY$713,1102025FOR 43 CHALLENGE PROJECT - ENGINEERED DESTABILIZED AU RICH ELEMENTS OF C-MYC 3UTR AS THERAPEUTICS FOR C-MYC DRIVEN PEDIATRIC CANCERS AND ONE CARON META IN EWING SARCOMA TRIAL
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTETAMPA, FL$657,7642025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    THE REGENTS OF THE UNIVERSITY OF CALIFORNIALOS ANGELES, CA$200,0002025FOR 43 CHALLENGE PROJECT - TREATING LEPTOMENINGEAL SPREAD OF PEDIATRIC MEDULLOBLASTOMA WITH QUANTUM RADIOBIOLOGY
    CLEVELAND CLINIC FOUNDATIONCLEVELAND, OH$192,4512025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INCTAMPA, FL$110,0002025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILLCHAPEL HILL, NC$102,5002025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CHILDREN'S RESEARCH INSTITUTESILVER SPRING, MD$95,0712025IN SUPORT OF INKT TRIAL CONDUCTED UNDER THE SUNSHINE PROJECT
    UNIVERSITY OF COLORADOAURORA, CO$91,6542025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    UNIVERSITY OF FLORIDAGAINESVILLE, FL$64,4172025IN SUPPORT OF CLINICAL TRIAL ADVANCING INKT STUDY
    JOHN HOPKINS UNIVERSITYBALTIMORE, MD$50,0002025IN SUPPORT OF CLINICAL TRIAL ADVANCING RHABDOMYOSARCOMA RESEARCH
    BAYCARE ST JOSEPH'S HOSPITAL INCCLEARWATER, FL$44,3062025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CONNECTICUT CHILDREN'S MEDICAL CENTERHARTFORD, CT$40,8562025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    VANDERBILT UNIVERSITY MEDICAL CENTERNASHVILLE, TN$37,9642025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    DUKE UNIVERSITYDURHAM, NC$37,1182025IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    ALBERT EINSTEIN COLLEGE OF MEDICINEBRONX, NY$820,0002024FOR 43 CHALLENGE PROJECT - ENGINEERED DESTABILIZED AU RICH ELEMENTS OF C-MYC 3UTR AS THERAPEUTICS FOR C-MYC DRIVEN PEDIATRIC CANCERS AND ONE CARON META IN EWING SARCOMA TRIAL
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTETAMPA, FL$603,9182024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    THE REGENTS OF THE UNIVERSITY OF CALIFORNIALOS ANGELES, CA$400,0002024FOR 43 CHALLENGE PROJECT - TREATING LEPTOMENINGEAL SPREAD OF PEDIATRIC MEDULLOBLASTOMA WITH QUANTUM RADIOBIOLOGY
    PARATOPE BIO INCWILMINGTON, DE$300,0002024FOR 43 CHALLENGE PROJECT - HARNESSING THE POWER OF INNATE ANTIBODIES FOR NOVEL THERAPIES IN PEDIATRIC CANCER RESEARCH
    THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITALDETROIT, MI$160,1542024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CHILDREN'S HOSPITAL OF COLORADO FOUNDATIONAURORA, CO$126,5262024BIOMARKER TRIAL PILLAR PROJECT CONDUCTED UNDER THE SUNSHINE PROJECT
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INCTAMPA, FL$100,1042024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILLCHAPEL HILL, NC$56,7632024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CONNECTICUT CHILDREN'S MEDICAL CENTERHARTFORD, CT$52,9712024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CHILDREN'S RESEARCH INSTITUTESILVER SPRING, MD$52,8892024IN SUPORT OF INKT TRIAL CONDUCTED UNDER THE SUNSHINE PROJECT
    JOHN HOPKINS UNIVERSITYBALTIMORE, MD$50,0002024IN SUPPORT OF CLINICAL TRIAL ADVANCING RHABDOMYOSARCOMA RESEARCH
    UNIVERSITY OF FLORIDAGAINESVILLE, FL$50,0002024IN SUPPORT OF CLINICAL TRIAL ADVANCING INKT STUDY
    DUKE UNIVERSITYDURHAM, NC$21,2102024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    VANDERBILT UNIVERSITY MEDICAL CENTERNASHVILLE, TN$12,0372024IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INCTAMPA, FL$850,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    ALBERT EINSTEIN COLLEGE OF MEDICINEBRONX, NY$770,0002023TWO RESEARCH STUDY GRANTS " TARGETING THE TUMOR MICROENVIRONMENT OF METASTASIS TO TREAT METASTATIC EWING SARCOMA AND"RE-PURPOSING HIV NUCLEOSIDE REVERSE TRANSCRIPTAS INHIBITORS FOR HIGH RISK NEROBLASTOME THERAPY"
    PARATOPE BIO INCWILMINGTON, DE$700,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTETAMPA, FL$528,6752023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTETAMPA, FL$487,0622023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    THE REGENTS OF THE UNIVERSITY OF CALIFORNIALOS ANGELES, CA$400,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    UNIVERSITY OF ALABAMATUSCALOOSA, AL$200,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    DUKE UNIVERSITYDURHAM, NC$168,0912023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILLCHAPEL HILL, NC$126,6712023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CLEVELAND CLINIC FOUNDATIONCLEVELAND, OH$124,8802023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CHILDREN'S HOSPITAL OF COLORADO FOUNDATIONAURORA, CO$112,8232023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CHILDREN'S HOSPITAL OF COLORADO FOUNDATIONAURORA, CO$109,3772023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    UNIVERSITY OF FLORIDAGAINESVILLE, FL$106,1722023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    NATIONWIDE CHILDREN'S HOSPITALCOLUMBUS, OH$100,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INCTAMPA, FL$100,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    MONTEFIORE CHILDREN'S HOSPITALTHE BRONX, NY$100,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    UNIVERSITY OF FLORIDAGAINESVILLE, FL$78,5162023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    UNIVERSITY OF COLORADOAURORA, CO$64,6882023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    CONNECTICUT CHILDREN'S MEDICAL CENTERHARTFORD, CT$56,7682023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    ST JUDE'S CHILDREN'S RESEARCH HOSPITALMEMPHIS, TN$50,0002023IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.
    ALBERT EINSTEIN COLLEGE OF MEDICINEBRONX, NY$50,0002023TWO RESEARCH STUDY GRANTS " TARGETING THE TUMOR MICROENVIRONMENT OF METASTASIS TO TREAT METASTATIC EWING SARCOMA AND"RE-PURPOSING HIV NUCLEOSIDE REVERSE TRANSCRIPTAS INHIBITORS FOR HIGH RISK NEROBLASTOME THERAPY"

    THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL

    $992,092
    DETROIT, MI2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    ALBERT EINSTEIN COLLEGE OF MEDICINE

    $713,110
    BRONX, NY2025

    FOR 43 CHALLENGE PROJECT - ENGINEERED DESTABILIZED AU RICH ELEMENTS OF C-MYC 3UTR AS THERAPEUTICS FOR C-MYC DRIVEN PEDIATRIC CANCERS AND ONE CARON META IN EWING SARCOMA TRIAL

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE

    $657,764
    TAMPA, FL2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

    $200,000
    LOS ANGELES, CA2025

    FOR 43 CHALLENGE PROJECT - TREATING LEPTOMENINGEAL SPREAD OF PEDIATRIC MEDULLOBLASTOMA WITH QUANTUM RADIOBIOLOGY

    CLEVELAND CLINIC FOUNDATION

    $192,451
    CLEVELAND, OH2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC

    $110,000
    TAMPA, FL2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILL

    $102,500
    CHAPEL HILL, NC2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CHILDREN'S RESEARCH INSTITUTE

    $95,071
    SILVER SPRING, MD2025

    IN SUPORT OF INKT TRIAL CONDUCTED UNDER THE SUNSHINE PROJECT

    UNIVERSITY OF COLORADO

    $91,654
    AURORA, CO2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    UNIVERSITY OF FLORIDA

    $64,417
    GAINESVILLE, FL2025

    IN SUPPORT OF CLINICAL TRIAL ADVANCING INKT STUDY

    JOHN HOPKINS UNIVERSITY

    $50,000
    BALTIMORE, MD2025

    IN SUPPORT OF CLINICAL TRIAL ADVANCING RHABDOMYOSARCOMA RESEARCH

    BAYCARE ST JOSEPH'S HOSPITAL INC

    $44,306
    CLEARWATER, FL2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CONNECTICUT CHILDREN'S MEDICAL CENTER

    $40,856
    HARTFORD, CT2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    VANDERBILT UNIVERSITY MEDICAL CENTER

    $37,964
    NASHVILLE, TN2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    DUKE UNIVERSITY

    $37,118
    DURHAM, NC2025

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    ALBERT EINSTEIN COLLEGE OF MEDICINE

    $820,000
    BRONX, NY2024

    FOR 43 CHALLENGE PROJECT - ENGINEERED DESTABILIZED AU RICH ELEMENTS OF C-MYC 3UTR AS THERAPEUTICS FOR C-MYC DRIVEN PEDIATRIC CANCERS AND ONE CARON META IN EWING SARCOMA TRIAL

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE

    $603,918
    TAMPA, FL2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

    $400,000
    LOS ANGELES, CA2024

    FOR 43 CHALLENGE PROJECT - TREATING LEPTOMENINGEAL SPREAD OF PEDIATRIC MEDULLOBLASTOMA WITH QUANTUM RADIOBIOLOGY

    PARATOPE BIO INC

    $300,000
    WILMINGTON, DE2024

    FOR 43 CHALLENGE PROJECT - HARNESSING THE POWER OF INNATE ANTIBODIES FOR NOVEL THERAPIES IN PEDIATRIC CANCER RESEARCH

    THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL

    $160,154
    DETROIT, MI2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CHILDREN'S HOSPITAL OF COLORADO FOUNDATION

    $126,526
    AURORA, CO2024

    BIOMARKER TRIAL PILLAR PROJECT CONDUCTED UNDER THE SUNSHINE PROJECT

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC

    $100,104
    TAMPA, FL2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILL

    $56,763
    CHAPEL HILL, NC2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CONNECTICUT CHILDREN'S MEDICAL CENTER

    $52,971
    HARTFORD, CT2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CHILDREN'S RESEARCH INSTITUTE

    $52,889
    SILVER SPRING, MD2024

    IN SUPORT OF INKT TRIAL CONDUCTED UNDER THE SUNSHINE PROJECT

    JOHN HOPKINS UNIVERSITY

    $50,000
    BALTIMORE, MD2024

    IN SUPPORT OF CLINICAL TRIAL ADVANCING RHABDOMYOSARCOMA RESEARCH

    UNIVERSITY OF FLORIDA

    $50,000
    GAINESVILLE, FL2024

    IN SUPPORT OF CLINICAL TRIAL ADVANCING INKT STUDY

    DUKE UNIVERSITY

    $21,210
    DURHAM, NC2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    VANDERBILT UNIVERSITY MEDICAL CENTER

    $12,037
    NASHVILLE, TN2024

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC

    $850,000
    TAMPA, FL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    ALBERT EINSTEIN COLLEGE OF MEDICINE

    $770,000
    BRONX, NY2023

    TWO RESEARCH STUDY GRANTS " TARGETING THE TUMOR MICROENVIRONMENT OF METASTASIS TO TREAT METASTATIC EWING SARCOMA AND"RE-PURPOSING HIV NUCLEOSIDE REVERSE TRANSCRIPTAS INHIBITORS FOR HIGH RISK NEROBLASTOME THERAPY"

    PARATOPE BIO INC

    $700,000
    WILMINGTON, DE2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE

    $528,675
    TAMPA, FL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE

    $487,062
    TAMPA, FL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

    $400,000
    LOS ANGELES, CA2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    UNIVERSITY OF ALABAMA

    $200,000
    TUSCALOOSA, AL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    DUKE UNIVERSITY

    $168,091
    DURHAM, NC2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    THE UNIVERSITY OF NORTH CARLINA AT CHAPEL HILL

    $126,671
    CHAPEL HILL, NC2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CLEVELAND CLINIC FOUNDATION

    $124,880
    CLEVELAND, OH2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CHILDREN'S HOSPITAL OF COLORADO FOUNDATION

    $112,823
    AURORA, CO2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CHILDREN'S HOSPITAL OF COLORADO FOUNDATION

    $109,377
    AURORA, CO2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    UNIVERSITY OF FLORIDA

    $106,172
    GAINESVILLE, FL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    NATIONWIDE CHILDREN'S HOSPITAL

    $100,000
    COLUMBUS, OH2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    H LEE MOFFIT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION INC

    $100,000
    TAMPA, FL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    MONTEFIORE CHILDREN'S HOSPITAL

    $100,000
    THE BRONX, NY2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    UNIVERSITY OF FLORIDA

    $78,516
    GAINESVILLE, FL2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    UNIVERSITY OF COLORADO

    $64,688
    AURORA, CO2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    CONNECTICUT CHILDREN'S MEDICAL CENTER

    $56,768
    HARTFORD, CT2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    ST JUDE'S CHILDREN'S RESEARCH HOSPITAL

    $50,000
    MEMPHIS, TN2023

    IN SUPPORT OF CLINICAL TRIALS CONDUCTED UNDER THE SUNSHINE PROJECT.

    ALBERT EINSTEIN COLLEGE OF MEDICINE

    $50,000
    BRONX, NY2023

    TWO RESEARCH STUDY GRANTS " TARGETING THE TUMOR MICROENVIRONMENT OF METASTASIS TO TREAT METASTATIC EWING SARCOMA AND"RE-PURPOSING HIV NUCLEOSIDE REVERSE TRANSCRIPTAS INHIBITORS FOR HIGH RISK NEROBLASTOME THERAPY"